| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Fibronectin; FN; Anastellin; Fn1 |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Expression System | |
| Gene ID | |
| Immunogen | Target protein isolated from mouse plasma |
| Product Type | |
| Reactivity | |
| Sample Type(s) | cell culture supernatants, serum and plasma (heparin, EDTA, citrate). |
| Sensitivity | |
| Storage | |
| Target | |
| UniProt # |
Background
Also known as: Fibronectin, FN, Anastellin, Fn1.
Mouse Fibronectin (FN1) is widely studied as a molecular readout in experimental models where changes in protein abundance reflect underlying biology. This target is frequently investigated in Immunology & Inflammation research contexts. Proteases and extracellular matrix (ECM) components are central to tissue architecture and remodeling. In many experimental contexts, changes in ECM-related proteins reflect shifts in cell adhesion, migration, barrier integrity, or matrix turnover.
Biological function and remodeling context
Matrix remodeling is influenced by the balance between synthesis and degradation, often regulated by inflammatory cues, mechanical stress, and growth-factor signaling. Protease activity can unmask or release bioactive fragments, while altered ECM composition can feed back on cell behavior through mechanotransduction and receptor engagement.
Why it matters in research
- Remodeling readout: Quantification can support studies of fibrosis, wound repair, and invasion models.
- Microenvironment state: Levels may reflect stromal activation, barrier disruption, or matrix turnover.
- Mechanistic linkage: Pairing with inflammatory and growth-factor markers can clarify drivers of remodeling.
Disease and translational relevance
ECM remodeling and protease regulation are frequently discussed in the literature across oncology, cardiovascular, pulmonary, and inflammatory disease models. Interpretation of abundance should consider whether the measured analyte represents pro-forms, active forms, or fragments, and whether binding partners in the matrix influence detectability.
Sample data
| Concentration (pg/ml) | 0 | 156 | 312 | 625 | 1250 | 2500 | 5000 | 10000 |
| O.D. | 0.034 | 0.092 | 0.14 | 0.22 | 0.397 | 0.691 | 1.251 | 1.91 |
Intra/inter assay consistency
| Intra-Assay Precision | Inter-Assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 16 | 16 | 16 | 24 | 24 | 24 |
| Mean (pg/ml) | 206 | 1683 | 4323 | 219 | 1843 | 3947 |
| Standard deviation | 13.39 | 126.22 | 293.96 | 15.54 | 160.34 | 335.49 |
| CV (%) | 6.5% | 7.5% | 6.8% | 7.1% | 8.7% | 8.5% |
Kit components
Description|Quantity Pre-coated 96-well strip microplate|1 Standard|2 vials Biotinylated antibody (100x)|100ul Avidin-Biotin-Peroxidase Complex (100x)|100ul Sample Diluent|30ml Antibody Diluent|12ml Avidin-Biotin-Peroxidase Diluent|12ml Color Developing Reagent (TMB)|10ml Stop Solution|10ml Wash Buffer (25x)|20ml Adhesive plate sealers|4Materials required but not provided
- Microplate Reader capable of reading absorbance at 450nm.
- Incubator.
- Automated plate washer (optional).
- Pipettes and pipette tips capable of precisely dispensing 0.5 µl through 1 ml volumes of aqueous solutions.
- Multichannel pipettes are recommended for large amount of samples.
- Deionized or distilled water.
- 500ml graduated cylinders.
- Test tubes for dilution.
►How many samples can I run per plate?
►What sample dilution should I use?
►Why is my signal weak or absent?
►Why is my background signal high?
►Are the kit components sterile?
►How do I analyze my ELISA results?
►How should I store samples before running the assay?
►What positive and negative controls should I include?
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
- Wang et al. (2024). CircRNA_012164/MicroRNA-9-5p axis mediates cardiac fibrosis in diabetic cardiomyopathy. PLoS One.
- Hu et al. (2024). Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extra…. Journal for ImmunoTherapy of Cancer.
- Zhang et al. (2023). Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and …. International Journal of Nanomedicine.
- Wang et al. (2023). Matrix stiffness regulates osteoclast fate through integrin-dependent mechanotransduction. Bioactive Materials.
- Yang et al. (2022). Emodin inhibiting epithelial-mesenchymal transition in pulmonary fibrosis through the c-MYC/miR-182-5p/ZEB2 axis. PHYTOTHERAPY RESEARCH.
- Altuntas et al. (2022). Local epidermal growth factor delivery using nanopillared chitosan–gelatin films for melanogenesis and wound healing. Biomaterials Science.
- Yi et al. (2022). Peptide nano-blanket impedes fibroblasts activation and subsequent formation of pre-metastatic niche. Nature Communications.
- Yunping et al. (2018). A Chinese Herbal Formula Ameliorates Pulmonary Fibrosis by Inhibiting Oxidative Stress via Upregulating Nrf2. Frontiers in Pharmacology.
- Thomas et al. (2018). ANRIL regulates production of extracellular matrix proteins and vasoactive factors in diabetic complications. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM.
- Shinji et al. (2018). RAGE Deletion Confers Renoprotection by Reducing Responsiveness to Transforming Growth Factor-β and Increasing Resistanc…. DIABETES.
- Xueli et al. (2017). Tuning the interactions between chiral plasmonic films and living cells. Nature Communications.
- Rani et al. (2016). Damage-associated molecular patterns (DAMPs) released after burn are associated with inflammation and monocyte activatio…. BURNS.